Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions caused by tissue stress and inflammation, including neuropathic pain and ...

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented ...

VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to ...

A sutureless device for peripheral nerve repair by medical technology company Tissium, which has its US office in Cambridge, could be available on the market in the coming months.

Moreover, SciatiEase Reviews frequently highlight inconsistent results: some customers report modest improvements in Sciatic ...

The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...

A burning sensation in the feet is usually harmless and temporary; however if it is chronic it can be due to various ...

The FDA cleared an artificial intelligence (AI)-powered wristband (Felix NeuroAI) to treat upper-limb functional limitations ...

Tissium announced today that it received FDA de novo marketing authorization for Coaptium Connect with Tissium Light.

The Global Neuropathic Pain Market is valued approximately at USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.73% over the forecast period 2024-2032.

The surgical sealant developer Tissium obtained a groundbreaking FDA clearance for its method of reconnecting severed nerves, ...

THE WOODLANDS, Texas, June 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that data from a study evaluating the impact of sotagliflozin on hypoglycemia in people ...